HomeDealsOkasa Pharmaceuticals

Okasa Pharmaceuticals

Deal Type
Deal Type
Company sale
Vital Sector
Sector
Healthcare
Completion Date
Completion Date
16th July 2015
Deal Value
Deal Value
Not disclosed

Company Background

Contract pharmaceutical manufacturer

Deal Summary

Medispray Laboratories Private Limited, a wholly owned subsidiary of Cipla acquired two manufacturing units from Okasa a related party of CIPLA. There were two legs to the transaction whereby the business were first transferred to the CIPLA subsidiary with the consent of the minority shareholders and then Hamsons purchased shares of the minority shareholders in the remaining company

Okasa Pharmaceuticals deal contacts

Key members of the Singhi Advisors Pvt. Ltd. deal team crucial in the Okasa Pharmaceuticals transaction

Mahesh Singhi

Singhi Advisors Pvt. Ltd.

Sreeraj Krishnamoorthy

Singhi Advisors Pvt. Ltd.